IROMAC-5 Injection
Elemental Iron 100 mg/5 ml Injection – PCD Pharma Franchise, Hospital & Wholesale Supply
| Composition | Iron Sucrose USP equivalent to elemental iron 20 mg per ml (100 mg per 5 ml ampoule) |
|---|---|
| Dosage Form | Injection (IV) |
| Pack Type | Tray Pack |
| Pack Size | 5 ml ampoule (tray pack) |
| MRP | ₹ 260 |
| Therapy | Gynaecology / Haematology – Iron deficiency — Parenteral (intravenous) iron |
| Storage | Store below 25 °C. Do not freeze. Keep the ampoule in the carton. Keep out of reach of children. |
📱 WhatsApp Enquiry📞 Call: +919041677932
For chemists, distributors and doctors: IROMAC-5 (iron 100 mg/5 ml injection) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
See the full injection & PFS range – manufacturer, supplier and PCD franchise: antibiotic, vitamin, pain, anti-emetic, hormone and critical-care injections in vials, ampoules and pre-filled syringes.
About IROMAC-5 Injection
IROMAC-5 is Trumac Healthcare’s iron sucrose injection (USP) containing elemental iron 20 mg in each ml – 100 mg of iron in each 5 ml ampoule – supplied in a tray pack and made for Trumac at WHO-GMP certified partner units.
Intravenous iron is used when iron-deficiency anaemia has to be corrected faster than tablets allow, or when oral iron does not work or is not tolerated – for example in pregnancy (second and third trimester), heavy menstrual bleeding, after surgery or childbirth, and in chronic kidney disease.
It is a regular hospital, nursing-home and gynaecology-clinic product, which makes it valuable for PCD franchise partners and distributors supplying institutions. The IROMAC range also covers oral iron tablets, suspension and drops for maintenance.
Indications
- Iron-deficiency anaemia when oral iron is ineffective, not tolerated or too slow
- Iron-deficiency anaemia in the second and third trimester of pregnancy and after childbirth, as decided by the doctor
- Iron deficiency in chronic kidney disease, as prescribed
Mechanism of Action
After intravenous administration the iron sucrose complex is taken up by the reticulo-endothelial system, mainly in the liver, spleen and bone marrow, where the iron is released and bound to transferrin and ferritin. It is then used by the bone marrow to make haemoglobin, so haemoglobin rises and body iron stores are refilled without depending on absorption from the gut.
Dosage & Administration
For intravenous use only, by a doctor or nurse in a setting where facilities to treat allergic reactions are available. The total dose is calculated by the doctor from body weight, haemoglobin and target iron stores, and is given in divided doses by slow intravenous injection or diluted infusion as per the product insert. Patients should be observed for at least 30 minutes after each dose. Not to be given at the same time as oral iron.
Side Effects
Taste disturbance, headache, nausea, dizziness, low blood pressure, flushing and pain or discoloration at the injection site. Serious allergic (anaphylactic) reactions can occur with any intravenous iron, rarely – the infusion must be stopped immediately and treated.
Contraindications & Precautions
Do not use in anaemia not caused by iron deficiency, in iron overload or disturbed iron use (e.g. haemochromatosis), in known serious allergy to the product or other parenteral irons, or in the first trimester of pregnancy. Use with caution in asthma, eczema or other allergies, active infection, and liver disease. Extravasation can stain the skin – give carefully into a vein.
Storage
Store below 25 °C. Do not freeze. Keep the ampoule in the carton. Keep out of reach of children.
IROMAC-5 Injection is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Oral iron in the same range: IROMAC-XT tablet · IROMAC-XT suspension · IROMAC-XT drops.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the injectable products franchise product list (PDF). See our full gynae PCD range. Comparing companies? See the compare injectable PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.
Frequently Asked Questions
Who supplies iron injection 100 mg/5 ml for PCD franchise?
IROMAC-5 is made for Trumac Healthcare at WHO-GMP certified partner units and offered on a PCD pharma franchise with monopoly rights for your district, and to hospital suppliers. No franchise fee; first order from ₹25,000.
What is the pack and MRP of IROMAC-5?
5 ml ampoule (elemental iron 100 mg) in a tray pack, MRP ₹260 as per the current product list. Orders are usually dispatched within 48 hours of confirmation.
Can hospitals and distributors buy IROMAC-5 on wholesale?
Yes. Licensed distributors, hospital suppliers and nursing homes can buy IROMAC-5 in bulk – message us on WhatsApp for net rates.
Is IROMAC-5 an oral drop?
No. IROMAC-5 is an injection for intravenous use. For oral iron, see IROMAC-XT tablets, suspension and drops.
How is IROMAC-5 given?
Only intravenously, by a doctor or nurse, as a slow injection or diluted infusion, with observation for at least 30 minutes afterwards.
Who should not receive intravenous iron?
Patients whose anaemia is not due to iron deficiency, those with iron overload, known serious allergy to injectable iron, and women in the first trimester of pregnancy.
